Literature DB >> 26484635

Mortality Trends in Crohn's Disease and Ulcerative Colitis: A Population-based Study in Québec, Canada.

Alain Bitton1, Maria Vutcovici, Maida Sewitch, Samy Suissa, Paul Brassard.   

Abstract

BACKGROUND: Mortality rates greater than in the general population have been reported in the population with Crohn's disease (CD), but reports for ulcerative colitis (UC) are conflicting. Trends with time were rarely described. We aimed to assess whether CD and UC mortality in Québec differs from that in the general population and to describe the trends over a 10-year observation period.
METHODS: This is a population-based cohort study using the Québec administrative health databases and death certificates registry. All-cause and cause-specific standardized mortality ratios (SMRs) were computed for 1999 to 2008. A time trend analysis was used to assess changes in the SMR with the calendar year.
RESULTS: All-cause mortality was significantly increased in CD and UC compared to the general population: SMR: CD 1.45 (95% confidence interval: 1.34-1.58), UC 1.21 (95% confidence interval: 1.12-1.32). In CD, mortality from digestive conditions, all neoplasms, digestive neoplasms, and colorectal, lymphatic, and lung cancer was significantly higher than in the general population. In UC, mortality from digestive, respiratory, and infectious conditions was also significantly increased. In both CD and UC, there was a decrease with time in all-cause SMRs and in digestive conditions, digestive neoplasms, colorectal cancer, and infectious diseases. SMRs for lung cancer and respiratory conditions increased over time in CD.
CONCLUSIONS: All-cause mortality was significantly higher in CD and UC populations than in the general population. However, a decreasing trend with time was observed in all-cause and some cause-specific SMRs. In CD, SMRs for lung cancer and respiratory conditions increased during the observation period.

Entities:  

Mesh:

Year:  2016        PMID: 26484635     DOI: 10.1097/MIB.0000000000000608

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  15 in total

1.  Mortality Is Rare Following Elective and Non-elective Surgery for Ulcerative Colitis, but Mild Postoperative Complications Are Common.

Authors:  Joseph D Feuerstein; Thomas Curran; Michael Alosilla; Thomas Cataldo; Kenneth R Falchuk; Vitaliy Poylin
Journal:  Dig Dis Sci       Date:  2018-01-20       Impact factor: 3.199

2.  Risk of Malignant Cancers in Inflammatory Bowel Disease.

Authors:  Simone Y Loo; Maria Vutcovici; Alain Bitton; Peter L Lakatos; Laurent Azoulay; Samy Suissa; Paul Brassard
Journal:  J Crohns Colitis       Date:  2019-09-27       Impact factor: 9.071

3.  Overall and Cause-Specific Mortality of Inflammatory Bowel Disease in Olmsted County, Minnesota, From 1970 Through 2016.

Authors:  Satimai Aniwan; W Scott Harmsen; William J Tremaine; Sunanda V Kane; Edward V Loftus
Journal:  Mayo Clin Proc       Date:  2018-07-04       Impact factor: 7.616

4.  Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.

Authors:  Remo Panaccione; A Hillary Steinhart; Brian Bressler; Reena Khanna; John K Marshall; Laura Targownik; Waqqas Afif; Alain Bitton; Mark Borgaonkar; Usha Chauhan; Brendan Halloran; Jennifer Jones; Erin Kennedy; Grigorios I Leontiadis; Edward V Loftus; Jonathan Meddings; Paul Moayyedi; Sanjay Murthy; Sophie Plamondon; Greg Rosenfeld; David Schwartz; Cynthia H Seow; Chadwick Williams; Charles N Bernstein
Journal:  J Can Assoc Gastroenterol       Date:  2018-07-10

5.  SRC-3 protects intestine from DSS-induced colitis by inhibiting inflammation and promoting goblet cell differentiation through enhancement of KLF4 expression.

Authors:  Wenbo Chen; Minghui Zhuo; Xuqiang Lu; Xiaochun Xia; Yang Zhao; Zhengrong Huang; Jianming Xu; Weihua Li; Chundong Yu
Journal:  Int J Biol Sci       Date:  2018-11-03       Impact factor: 6.580

6.  Investigation of adherent-invasive E. coli in patients with Crohn's disease.

Authors:  Akram Sarabi Asiabar; Hamid Asadzadeh Aghdaei; Azar Sabokbar; Mohammad Reza Zali; Mohammad Mehdi Feizabadi
Journal:  Med J Islam Repub Iran       Date:  2018-02-11

7.  The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.

Authors:  Gilaad G Kaplan; Charles N Bernstein; Stephanie Coward; Alain Bitton; Sanjay K Murthy; Geoffrey C Nguyen; Kate Lee; Jane Cooke-Lauder; Eric I Benchimol
Journal:  J Can Assoc Gastroenterol       Date:  2018-11-02

8.  Crohn's disease-specific mortality: a 30-year cohort study at a tertiary referral center in Japan.

Authors:  Shigeyoshi Yasukawa; Toshiyuki Matsui; Yutaka Yano; Yuho Sato; Yasumichi Takada; Masahiro Kishi; Yoichiro Ono; Noritaka Takatsu; Takashi Nagahama; Takashi Hisabe; Fumihito Hirai; Kenshi Yao; Toshiharu Ueki; Daijiro Higashi; Kitaro Futami; Suketo Sou; Toshihiro Sakurai; Tsuneyoshi Yao; Hiroshi Tanabe; Akinori Iwashita; Masakazu Washio
Journal:  J Gastroenterol       Date:  2018-06-09       Impact factor: 7.527

9.  Mortality After First Hospital Admission for Inflammatory Bowel Disease: A Nationwide Registry Linkage Study.

Authors:  Jorrit L Opstelten; Ilonca Vaartjes; Michiel L Bots; Bas Oldenburg
Journal:  Inflamm Bowel Dis       Date:  2019-09-18       Impact factor: 5.325

10.  Trends and risk factors of mortality analysis in patients with inflammatory bowel disease: a Taiwanese nationwide population-based study.

Authors:  Wei-Chen Lin; Meng-Tzu Weng; Chien-Chih Tung; Yuan-Ting Chang; Yew-Loong Leong; Yu-Ting Wang; Horng-Yuan Wang; Jau-Min Wong; Shu-Chen Wei
Journal:  J Transl Med       Date:  2019-12-12       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.